By Emeritus Professor Andrew Lloyd

Books

, 2009, Hepatitis C: An Expanding Perspective, Dore GJ; Dore G; Lloyd AROLA, (eds.), IP Communications, East Hawthorn

Book Chapters

Lloyd AR; Hickie I; Wakefield D, 2022, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology Third Edition, pp. 371 - 383, http://dx.doi.org/10.1128/9781555815981.ch17

Cameron B; Bierl C; Davenport T; Vollmer-Conna U; Hickie I; Wakefield D; Lloyd AR, 2021, 'Drought and Q fever: The association between trends in the incidence of infection and rainfall in rural Australia', in The Encyclopedia of Bacteriology Research Developments, pp. 1975 - 1988

Chang CC; Crane M; Jaworowski A; Lloyd A; French MA; Lewin SR, 2018, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1083 - 1096, http://dx.doi.org/10.1007/978-1-4939-7101-5_179

Cameron B; Bierl C; Davenport T; Vollmer-Conna U; Hickie I; Wakefield D; Lloyd AR, 2017, 'Drought and q fever: The association between trends in the incidence of infection and rainfall in rural australia', in Principles and Practice of Q Fever the One Health Paradigm, pp. 301 - 315

Lloyd A, 2017, 'Chronic Fatigue and Postinfective Fatigue Syndromes', in Clinical Virology, Fourth Edition, American Society for Microbiology, pp. 373 - 384, http://dx.doi.org/10.1128/9781555819439.ch18

Lloyd AR, 2016, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology, pp. 371 - 384, http://dx.doi.org/10.1128/9781555819439.ch18

Chang CC; Crane M; Jaworowski A; Lloyd A; French MA; Lewin SR, 2014, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1 - 15, http://dx.doi.org/10.1007/978-1-4614-9610-6_179-1

Oldmeadow M; Lloyd AROLA, 2009, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, IP Communications, East Hawthorn, Victoria, Australia

Dore GJ; Temple-Smith M; Lloyd AROLA, 2009, 'Future challenges for hepatitis C', in Dore G; Temple-Smith M; Lloyd A (ed.), Hepatitis C: An Expanding Perspective, IP Communications, East Hawthorn, pp. 433 - 452, http://www.ipcommunications.com.au/

Oldmeadow M; Lloyd AR, 2005, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, IP Communications, East Hawthorn, Victoria, Australia, pp. 195 - 204

Lloyd AR; Hickie IB; Petersen PK, 1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment', in Current Clinical Topics in Infectious Diseases, Blackwell Science Asia, Carlton, Victoria, pp. 138 - 159

Lloyd AR; Hickie IB; Peterson PK, 1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment.', in Current Clinical Topics in Infectious Diseases, Blackwell Science Asia, Carlton, Victoria, pp. 135 - 159

Lloyd AR; Hickie IB; Peterson PK, 1997, 'Chronic fatigue syndrome', in Clinical Virology, Churchill Livingstone, New York, pp. 343 - 355

Lloyd AR; Hickie IB; Peterson PK, 1997, 'Chronic fatigue syndrome', in Clinical Virology, Churchill Livingstone, New York, pp. 343 - 355

Lloyd AR; Wakefield D, 1997, 'Treatment of chronic fatigue syndrome', in Intravenous Immunoglobulins in Clinical Practice, Marcel Dekker, New York, pp. 267 - 274

DWYER JM; LLOYD AR; HICKIE IB; WAKEFIELD D; BOUGHTON CR, 1991, 'The response of patients with chronic fatigue syndrome to intravenously administered gammaglobulin', in Immunotherapy with Intravenous Immunoglobulins, Elsevier, pp. 377 - 386, http://dx.doi.org/10.1016/b978-0-12-370725-3.50039-7

Journal articles

Lafferty L; Brown T; McGrath C; Wright T; Henderson C; Lloyd AR; Grebely J; Treloar C, 2025, 'Implications of the fragility of opioid agonist treatment continuity on hepatitis C re-exposure concerns among people in prison: a qualitative study', International Journal of Drug Policy, 142, pp. 104831 - 104831, http://dx.doi.org/10.1016/j.drugpo.2025.104831

Jamali E; Quadeer AA; Tedla N; McKay MR; Lloyd A; Walker MR; Bull RA, 2025, 'Anti-HCV antibodies: A battle for breadth and potency', Antiviral Research, 238, http://dx.doi.org/10.1016/j.antiviral.2025.106165

Tonini E; Crouse JJ; Shin M; Carpenter JS; Lloyd AR; Hindmarsh G; McKenna S; Nichles A; Zmicerevska N; Scott J; Iorfino F; Pantelis C; Nelson B; McGorry PD; Wood SJ; Yung AR; Purcell R; Hickie IB, 2025, 'Multidimensional outcomes associated with chronic fatigue over 12 months in youth with emerging mood disorders', Journal of Psychosomatic Research, 193, http://dx.doi.org/10.1016/j.jpsychores.2025.112141

Sazzad HMS; Li H; Hajarizadeh B; Horsburgh BA; Grebely J; Dore GJ; Bull RA; Lloyd AR; Rodrigo C, 2025, 'Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics', Virus Research, 355, http://dx.doi.org/10.1016/j.virusres.2025.199566

Maduranga S; Shrestha LB; Valencia BM; Horton G; Guppy M; Gidding HF; Graves S; Stenos J; Rawlinson W; Lloyd AR; Rodrigo C, 2025, 'Diagnosing and Preventing Q Fever in Regional New South Wales, Australia—A Qualitative Exploration of Perspectives of General Practitioners', Australian Journal of Rural Health, 33, http://dx.doi.org/10.1111/ajr.70030

Li V; McKay FC; Tscharke DC; Smith C; Khanna R; Lechner-Scott J; Rawlinson WD; Lloyd AR; Taylor BV; Morahan JM; Steinman L; Giovannoni G; Bar-Or A; Levy M; Drosu N; Potter A; Caswell N; Smith L; Brady EC; Frost B; Hodgkinson S; Hardy TA; Broadley SA, 2025, 'Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach', CNS Drugs, 39, pp. 305 - 320, http://dx.doi.org/10.1007/s40263-024-01153-5

Moallemi S; Tedla N; Sigera C; Weeratunga P; Fernando D; Rajapakse S; Lloyd AR; Rodrigo C, 2025, 'Early circulating biomarkers to predict plasma leakage in dengue fever', Journal of Infection, 90, http://dx.doi.org/10.1016/j.jinf.2024.106401

Gervais A; Bastard P; Bizien L; Delifer C; Tiberghien P; Rodrigo C; Trespidi F; Angelini M; Rossini G; Lazzarotto T; Conti F; Cassaniti I; Baldanti F; Rovida F; Ferrari A; Mileto D; Mancon A; Abel L; Puel A; Cobat A; Rice CM; Cadar D; Schmidt-Chanasit J; Scheid JF; Lemieux JE; Rosenberg ES; Agudelo M; Tangye SG; Borghesi A; Durand GA; Duburcq-Gury E; Valencia BM; Lloyd AR; Nagy A; Macdonald MM; Simonin Y; Zhang SY; Casanova JL, 2024, 'Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease', Journal of Experimental Medicine, 221, http://dx.doi.org/10.1084/jem.20240942

Shrestha LB; Tungatt K; Aggarwal A; Stubis A; Fewings NL; Fichter C; Akerman A; Rodrigo C; Tedla N; Lee S; Lloyd AR; Brilot F; Britton WJ; Kelleher A; Caterson ID; Douglas MW; Rockett R; Tangye SG; Triccas JA; Turville SG; Sandgren KJ; Bull RA; Cunningham AL; Sorrell T; Maclean M; Camilleri J; Douglas M; Song Y; Mao L; Phu A; Sigmund A; Beard S; Hunt S; Vande More AM; Kandasamy R; Kok J; Byrne J; Lloyd A; Tangye S; O'Sullivan M; Steain M; Baird S; Phetsouphanh C; Zhao Y, 2024, 'Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants', Ebiomedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105461

Walker SJ; Dawson O; Sheehan Y; Shrestha LB; Lloyd AR; Sheehan J; Maduka N; Cabezas J; Kronfli N; Akiyama MJ, 2024, 'Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework', International Journal of Drug Policy, 134, http://dx.doi.org/10.1016/j.drugpo.2024.104628

Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B; Bah R; Li C; Byrne M; Butler T; Musarurwa B; Hooshmand E; Simpson A; Alrayyani M; Price N; Groom M, 2024, 'Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep study', Lancet Regional Health Western Pacific, 53, http://dx.doi.org/10.1016/j.lanwpc.2024.101240

Ryan H; Dore GJ; Grebely J; Byrne M; Cunningham EB; Martinello M; Lloyd AR; Hajarizadeh B, 2024, 'Hepatitis C treatment outcome among people in prison: The SToP-C study', Liver International, 44, pp. 2996 - 3007, http://dx.doi.org/10.1111/liv.16074

Nibau C; Evans A; King H; Phillips DW; Lloyd A, 2024, 'Homoeologous crossovers are distally biased and underlie genomic instability in first-generation neo-allopolyploid Arabidopsis suecica', New Phytologist, 244, pp. 1315 - 1327, http://dx.doi.org/10.1111/nph.20095

Horsburgh BA; Walker GJ; Kelleher A; Lloyd AR; Bull RA; Giallonardo FD, 2024, 'Next-Generation Sequencing Methods for Near-Real-Time Molecular Epidemiology of HIV and HCV', Reviews in Medical Virology, 34, http://dx.doi.org/10.1002/rmv.70001

Underwood AP; Gupta M; Wu BR; Eltahla AA; Boo I; Wang JJ; Agapiou D; Abayasingam A; Reynaldi A; Keoshkerian E; Zhao Y; Brasher N; Walker MR; Bukh J; Maher L; Gordon T; Davenport MP; Luciani F; Drummer HE; Lloyd AR; Bull RA, 2024, 'B-cell characteristics define HCV reinfection outcome', Journal of Hepatology, 81, pp. 415 - 428, http://dx.doi.org/10.1016/j.jhep.2024.04.004

Lafferty L; Altice FL; Leone F; Stoové M; Lloyd AR; Hajarizadeh B; Kronfli N, 2024, 'Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake', International Journal of Drug Policy, 131, http://dx.doi.org/10.1016/j.drugpo.2024.104549

Rodrigo C; Walker G; Sevendal ATK; Nguyen C; Stelzer-Braid S; Rawlinson W; Graves S; Gidding HF; Stenos J; Lloyd AR, 2024, 'Acute Q fever in patients with an influenza-like illness in regional New South Wales, Australia', Plos Neglected Tropical Diseases, 18, http://dx.doi.org/10.1371/journal.pntd.0012385

Cai C; Keoshkerian E; Wing K; Samir J; Effenberger M; Schober K; Bull RA; Lloyd AR; Busch DH; Luciani F, 2024, 'Discovery of a monoclonal, high-affinity CD8+ T-cell clone following natural hepatitis C virus infection', Immunology and Cell Biology, 102, pp. 630 - 641, http://dx.doi.org/10.1111/imcb.12791

Sheehan Y; Cochrane A; Treloar C; Grebely J; Tedla N; Lloyd AR; Lafferty L, 2024, 'Understanding hepatitis C virus (HCV) health literacy and educational needs among people in prison to enhance HCV care in prisons', International Journal of Drug Policy, 130, http://dx.doi.org/10.1016/j.drugpo.2024.104516

Kronfli N; Lafferty L; Leone F; Stoové M; Hajarizadeh B; Lloyd AR; Altice FL, 2024, 'Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers', International Journal of Drug Policy, 130, http://dx.doi.org/10.1016/j.drugpo.2024.104540

Griffin S; Lee Wilkinson A; Winter R; Hajarizadeh B; MacIsaac M; Papaluca T; Holmes J; Lloyd AR; Carson J; Craigie A; Hellard M; Stoové M; Thompson A, 2024, 'Contribution of prison-based hepatitis C treatment initiations to overall treatment uptake in Victoria, Australia', Lancet Regional Health Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101139

Sheehan Y; Lafferty L; Tedla N; Byrne M; Dawson O; Stewart S; Leber B; Habraken N; Lloyd AR, 2024, 'Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd)', International Journal of Drug Policy, 129, http://dx.doi.org/10.1016/j.drugpo.2024.104461

Bretaña NA; Kwon JA; Grant L; Galouzis J; McGrath C; Hoey W; Blogg J; Lloyd AR; Gray RT, 2024, 'Controlling COVID-19 outbreaks in the correctional setting: A mathematical modelling study', Plos One, 19, http://dx.doi.org/10.1371/journal.pone.0303062

Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N, 2024, 'Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit', International Journal of Drug Policy, 126, http://dx.doi.org/10.1016/j.drugpo.2024.104386

Winter RJ; Griffin S; Sheehan Y; Nguyen W; Stoové M; Lloyd AR; Thompson AJ, 2024, 'People in community corrections are a population with unmet need for viral hepatitis care', Eclinicalmedicine, 70, http://dx.doi.org/10.1016/j.eclinm.2024.102548

Sheehan Y; Grebely J; Lloyd AR, 2024, 'Reply to: “ ‘One-stop-shop’ point-of-care hepatitis C RNA testing intervention in the prison – some issues”', Journal of Hepatology, 80, pp. e107 - e108, http://dx.doi.org/10.1016/j.jhep.2023.10.020

Shih STF; Stone J; Martin NK; Hajarizadeh B; Cunningham EB; Kwon JA; McGrath C; Grant L; Grebely J; Dore GJ; Lloyd AR; Vickerman P; Chambers GM, 2024, 'Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination', Open Forum Infectious Diseases, 11, pp. ofad637, http://dx.doi.org/10.1093/ofid/ofad637

Weickert TW; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks WS; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd AR; Stanton C; O'Donnell M; Liu D; Galletly C; Shannon Weickert C, 2024, 'Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial', Brain Behavior and Immunity, 115, pp. 191 - 200, http://dx.doi.org/10.1016/j.bbi.2023.10.012

Bah R; Sheehan Y; Li X; Price N; Butler T; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2024, 'Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2024.104401

Adhikari A; Abayasingam A; Brasher NA; Kim HN; Lord M; Agapiou D; Maher L; Rodrigo C; Lloyd AR; Bull RA; Tedla N, 2024, 'Characterization of antibody-dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes', Journal of Medical Virology, 96, http://dx.doi.org/10.1002/jmv.29381

Kwon JA; Bretaña NA; Kronfli N; Dussault C; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd AR; Gray RT, 2024, 'Corrigendum: Preparing correctional settings for the next pandemic: a modeling study of COVID-19 outbreaks in two high-income countries (Frontiers in Public Health, (2024), 12, (1279572), 10.3389/fpubh.2024.1279572)', Frontiers in Public Health, 12, http://dx.doi.org/10.3389/fpubh.2024.1478843

Hajarizadeh B; Carson JM; Byrne M; Grebely J; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Lloyd AR; Dore GJ, 2024, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, 31, pp. 21 - 34, http://dx.doi.org/10.1111/jvh.13895

Kwon JA; Bretaña NA; Kronfli N; Dussault C; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd AR; Gray RT, 2024, 'Preparing correctional settings for the next pandemic: a modeling study of COVID-19 outbreaks in two high-income countries', Frontiers in Public Health, 12, http://dx.doi.org/10.3389/fpubh.2024.1279572

Back to profile page